Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Human immunodeficiency virus
100%
Pre-Exposure Prophylaxis
34%
Men Who Have Sex with Men
30%
Sexually Transmitted Disease
25%
Infection
19%
HIV Test
14%
Prevalence
11%
Mixed Methods
11%
Oral
10%
Antiretroviral Therapy
10%
Antibiotic Resistance
9%
Tuberculosis
9%
COVID-19
9%
Sexually Transmitted Infection
8%
Sexual Behavior
8%
Diseases
7%
Retrospective Cohort Study
6%
Monkeypox
6%
Returning Traveler
6%
Ethiopia
6%
Odds Ratio
6%
Chlamydiae
6%
Cross Sectional Study
6%
Drug Use
6%
Post-Exposure Prophylaxis
6%
Chlamydia Trachomatis
6%
Gonorrhea
6%
Neisseria gonorrhoeae
5%
Antiinfective Agent
5%
Dolutegravir
5%
Monkeypox Virus
5%
Macrolide
5%
Immunology and Microbiology
Human immunodeficiency virus
55%
Infection
35%
Infectious Disease
35%
Prevalence
15%
Neisseria gonorrhoeae
14%
Minimum Inhibitory Concentration
12%
Human Immunodeficiency Virus 1
11%
Neisseria
11%
T Cell
9%
Antibiotic Resistance
8%
Cytotoxic T-Cell
8%
Viral Load
8%
Galleria mellonella
7%
Virus Infection
7%
In Vitro
7%
Monkeypox Virus
7%
Hepatitis C
7%
COVID-19
7%
Hepatitis C Virus
6%
Human Immunodeficiency Virus Infection
6%
Chlamydiae
6%
Antibiotic Sensitivity
6%
Escherichia coli
5%
Klebsiella pneumoniae
5%
Blood Plasma
5%
Arm
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
39%
Infection
14%
Antiinfective Agent
13%
Prevalence
11%
Gonorrhea
8%
Neisseria gonorrhoeae
8%
Sexually Transmitted Disease
8%
Macrolide
8%
Antibiotic Resistance
8%
Doxycycline
7%
Quinolone Derivative
5%
Dolutegravir
5%
Mycoplasma genitalium
5%